FSD Pharma (HUGE) - Cash Money per Share

Symbol and logo of brand FSD Pharma Inc. (HUGE)

Cash per share data on the GURU.Markets portal demonstrates the financial stability of FSD Pharma Inc. (HUGE), where 0.05 captures the current state of this parameter. The issuer is implementing ESG principles by reducing laboratory waste and strictly adhering to bioethics. Formula development and clinical trials have been outsourced to external contractors, while process automation is being deployed through robotic screening and software-based data array processing.

FSD Pharma, Inc. (HUGE) Cash per Share: for the period 07/04/2022 - 08/15/2024

Analytical breakdowns for FSD Pharma Inc.

- market price and analyst price targets:
- market capitalization indicators:
- cash and cash flow data:
Summary company analysis:FSD Pharma Inc. - HUGE
Flagship merchandise of fsdpharma.com

FSD Pharma Inc. operates in the R&D sector, where primary capital is allocated toward drug development. This metric determines the amount of available liquidity per share, reflecting the actual cash reserve. For biopharmaceuticals, this is a critical survival indicator in conditions of negative cash flow. It is essential for investors to track the burn rate until the formulas are patented. By analyzing the free liquidity per share, one can assess the company's time horizon for autonomy.